Physician profile
Diane Walder
NPI 1588697221
$2,946.85
in general payments reported to CMS, 2019-2025
18 companies · $492 in 2025
The $492 reported for 2025 was more than what 78% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $378 · 2020: $99.55 · 2021: $287 · 2022: $459 · 2023: $738 · 2024: $493 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,723.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,281.22 | 2023-2025 | Botox, Skyrizi |
| Allergan, INC. | $741.45 | 2019-2022 | |
| Galderma Laboratories, L.P. | $333.29 | 2019-2025 | Dysport, Oracea, Aklief |
| Pfizer INC. | $80.37 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $76.80 | 2023-2025 | Blu-U, Odomzo |
| Merz North America, INC. | $72.54 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $70.61 | 2019 | |
| Revance Therapeutics, INC. | $52.05 | 2024 | Daxxify |
| Organon LLC | $46.76 | 2025 | |
| Clozex Medical INC | $39.47 | 2022 | |
| Smith+Nephew, INC. | $24.16 | 2024 | Pico 14 |
| Aclaris Therapeutics, INC. | $20.95 | 2019 | |
| Janssen Biotech, INC. | $20.26 | 2022 | |
| Acera Surgical, INC. | $19.54 | 2022 | |
| Cipher Pharmaceuticals US LLC | $19.25 | 2025 | Natroba, Spinosad |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $17.73 | 2023 | |
| Verrica Pharmaceuticals INC. | $17.15 | 2025 | Ycanth |
| Strata Skin Sciences, INC. | $13.25 | 2023 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Walder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.